CEPI awards USD 14.1 mn to Bharat Biotech consortium for Chikungunya antibody Kumar Jeetendra | June 3, 2020 The Coalition for Epidemic Preparedness Innovations (CEPI) will give a store of USD 14.1 million to a consortium, involving Bharat Biotech and International Vaccine Institute (IVI), for antibody fabricating and clinical advancement of a two-portion live-inactivated immunization (BBV87) against Chikungunya. CEPI is an imaginative association between open, private, altruistic, and common associations, propelled at Davos …
